Pomegra
Czech AI radiology startup Carebot raised over €1.5M led by Garage Angels and Electron Capital, with a larger round of up to €10M now in preparation.
Key Takeaways
- Carebot raised more than €1.5M (over CZK 36M), its largest round to date, announced in late July 2026.
- Garage Angels and Electron Capital Partners led. JIC Ventures joined, and Gain Ventures and Eva Janečková stayed in.
- Valuation is undisclosed. A further round of up to €10M is being prepared.
Lead
Carebot, a Brno-based developer of AI software for reading medical images, has closed an investment of more than €1.5M, equal to over CZK 36M. The company announced the round in late July 2026 and described it as the largest in its history. Garage Angels and Electron Capital Partners led it, JIC Ventures is a new investor, and existing backers Gain Ventures and private investor Eva Janečková took part again. The company has not disclosed a valuation.
The announcement did not label the round a Series A, despite some descriptions of it as one. Carebot says it is preparing a larger raise of up to €10M, which is the more likely candidate for a conventional Series A.
What Did Carebot Announce?
Carebot announced the funding together with a new product, Carebot AI MMG, a mammography tool that flags suspicious findings and helps radiologists rule out breast cancer. The company says the software is right 99.6% of the time when it marks a scan as negative. It also says about 30% of Czech mammography facilities already use its technology.
Founders Matěj Misař (CEO) and Daniel Kvak started the company in Brno. Its software already runs in hundreds of hospital facilities across eight European countries and the United Arab Emirates. Czech customers include University Hospital Olomouc, Nemocnice Na Bulovce and St. Anne's University Hospital in Brno.
Why Does the Round Matter Beyond the Headline Number?
The round matters because it shows how slowly capital has arrived at a company that is already selling. Carebot raised roughly €800,000 early on, then €1.2M (CZK 30M) in March 2024 from investors including Pilulka Lab, Startguide VC, BHM Group and Gain Ventures. The latest round is only about 25% larger than that 2024 tranche.
The commercial figures are stronger than the financing. Carebot reports that contracted monthly recurring revenue rose 750% over the past year. It also says contracted agreements could lift revenue tenfold by the end of 2026. Those are company figures, and a 750% gain from a small base says less than the same percentage at scale. Absolute revenue was not disclosed.
The pairing of a modest round with a planned €10M raise suggests this money bridges the gap. It funds the mammography launch and hospital rollouts while the company prepares a pitch to larger funds.
What Does Carebot Sell?
Carebot sells AI software that reads radiological images and sends the results to the doctor's workstation. The line has three products:
- Carebot AI CXR analyses chest X-rays for signs of lung disease, including potential cancer.
- Horizon by Carebot covers fractures, bone age and skeletal measurements.
- Carebot AI MMG is the newly launched mammography tool.
The company competes with larger imaging-AI vendors such as Lunit, Aidoc and Annalise.ai. Its pitch to hospitals is regulatory clearance for European use combined with local support in Central European markets. The March 2024 round followed an international certification, which opened wider European sales.
Who Backs the Company?
The investor group mixes angel and institutional money. Garage Angels is a Czech angel network. Electron Capital Partners and JIC Ventures are venture investors, and JIC is tied to the South Moravian Innovation Centre in Brno. Gain Ventures and Eva Janečková, who were in the 2024 round, returned, so existing investors are backing the company again as it grows.
What Comes Next?
Carebot will use the proceeds to build more AI products, extend hospital deployments into new markets and widen access for physicians and patients. The company has also stated global ambitions, with Vietnam and the UAE already among its customers. The next test is whether it can close the planned round of up to €10M at a valuation that reflects its revenue growth.
Reimbursement and hospital procurement cycles remain the main drag for imaging-AI vendors in Europe. A faster-than-expected sales ramp would ease that constraint. A slower one would leave Carebot reliant on the larger raise to fund its pipeline.
Outlook
Carebot's €1.5M round is small in absolute terms but is the largest the company has raised. It is led by Garage Angels and Electron Capital, with a valuation and Series A designation still absent. The company has a three-product portfolio, a new mammography tool and reported revenue growth of 750%. Its next financing, targeted at up to €10M, will show whether investors price those results as a regional success or a scalable European platform.
